The present SARS Cov-2 pandemic represented an unprecedented challenge for both public health and the economy around the world.
Freia Farmaceutici has activated specific clinical research lines to identify new therapeutic solutions with a low economic impact and to control inflammatory processes associated with SARS Cov-2 infection.
Lastly, a specific product line was developed to ensure adequate procedures for hands and work surfaces sanitation as indicated by the World Health Organization.


